Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2015-09-09 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Goldman Sachs 12th European Medtech & Healthcare Services Conference
Investor Presentation Classification · 99% confidence The document text is clearly a presentation given at the 'Goldman Sachs European Medtech and Healthcare Services Conference' on September 9-10, 2015. It contains slides summarizing business segments (Fresenius Medical Care, Kabi, Helios, Vamed), financial results for Q2/H1 2015, outlook updates, and dividend information. This format, which is a detailed presentation intended for investors, aligns perfectly with the definition of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K, nor is it a short announcement of a report (RPA/RNS).
2015-09-09 English
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting Rights Announcements' and details notifications received pursuant to 'section 21 para. 1 WpHG' (German Securities Trading Act) regarding changes in the percentage of voting rights held by various entities, crossing the 3% threshold. This directly corresponds to the definition of a Major Shareholding Notification (MRQ) or, given the explicit mention of 'Voting Rights Announcements' in the header, it aligns closely with the concept covered by DVA (Declaration of Voting Results & Voting Rights Announcements). Since the content is about changes in ownership thresholds (major shareholding notification) rather than the results of a vote already taken (DVA), MRQ is the most precise fit for reporting changes in significant share ownership levels crossing thresholds. However, the document explicitly uses the term 'Voting Rights Announcement' which is a strong indicator for DVA, even if the content describes a threshold crossing event typical of MRQ. Given the options, 'Voting Rights Announcements' maps most directly to DVA, which covers announcements related to voting rights, even if it's a threshold notification rather than final vote results. Let's re-evaluate: MRQ is for 'Notification of changes in significant share ownership levels (crossing thresholds)'. DVA is for 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Since this is a notification of a threshold crossing (3.006%), MRQ is technically more accurate based on the provided definitions, despite the document's header using 'Voting Rights Announcement'. I will classify it as MRQ based on the content describing a threshold crossing event.
2015-09-03 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document explicitly uses the header "Directors’ Dealings" and details a transaction made by a person in a managerial responsibility position ('Member of an administrative or supervisory body'). It specifies the name of the person (Gerd Krick), the type of transaction (Purchase), the date, price, and number of shares. This content directly corresponds to the definition of Director's Dealing, which maps to the filing code DIRS.
2015-09-01 English
Release according to Article 26a of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is extremely short (1330 characters) and announces a specific metric: the 'Total Voting Rights' as of August 31, 2015. It explicitly states it is a 'Total Voting Rights Announcement according to Article 26a of the WpHG'. This type of announcement, which reports on the total number of shares with voting rights, is not explicitly covered by the primary definitions (like 10-K, ER, or DIV). However, it is a formal regulatory disclosure concerning share structure and voting power. Among the provided codes, 'DVA' (Declaration of Voting Results & Voting Rights Announcements) is the closest fit, as it deals directly with voting rights, even though this specific document is a periodic update rather than the final result of a specific vote. Given the nature of the announcement (a formal regulatory disclosure about voting rights), DVA is the most appropriate classification.
2015-08-31 English
DGAP-DD: Fresenius SE & Co. KGaA english
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains detailed information about a transaction performed by a person in a managing body ('Sturm, Stephan, Member of a managing body'). It reports the exercise of stock options and sale of shares, which falls directly under the definition of insider trading or director transactions. This corresponds precisely to the 'Director's Dealing' category (DIRS). The presence of 'DGAP-DD' (DGAP - Directors' Dealings) further confirms this classification.
2015-08-18 English
Factsheet H1/2015
Fund Information / Factsheet Classification · 98% confidence The document is explicitly titled '# Factsheet H1/2015' and contains summarized financial data, key figures for H1/2015 compared to H1/2014 and 2014, segment breakdowns, share performance, and an outlook for 2015. This structure—a concise summary of key financial and operational highlights for a specific interim period (H1/2015)—is characteristic of a Fund Information / Factsheet (FS). It is not a comprehensive regulatory report like a 10-K or a detailed Interim Report (IR), nor is it an announcement of a report (RPA).
2015-08-13 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.